Contact dermatitis to bufexamac.
D000328:Adult; D002019:Bufexamac / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006877:Hydroxamic Acids / Q000009:adverse effects*; D007223:Infant; D008297:Male; D009824:Ointments; D010787:Photosensitivity Disorders / Q000139:chemically induced*
D006877:Hydroxamic Acids; D009824:Ointments; D002019:Bufexamac